Detalles de la búsqueda
1.
Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent.
Catheter Cardiovasc Interv
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38713843
2.
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials.
Neth Heart J
; 32(6): 254-261, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38776038
3.
Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
Catheter Cardiovasc Interv
; 102(2): 221-232, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37232278
4.
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
Cardiovasc Diabetol
; 20(1): 217, 2021 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34717627
5.
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
Catheter Cardiovasc Interv
; 98(2): E188-E196, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33694294
6.
First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial.
Circ J
; 85(11): 1983-1990, 2021 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34261828
7.
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.
Am Heart J
; 228: 109-115, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32882569
8.
Thin, very thin, or ultrathin-strut biodegradable or durable polymer-coated drug-eluting stents.
Curr Opin Cardiol
; 35(6): 705-711, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32852343
9.
Three contemporary thin-strut drug-eluting stents implanted in severely calcified coronary lesions of participants in a randomized all-comers trial.
Catheter Cardiovasc Interv
; 96(5): E508-E515, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32237060
10.
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
Catheter Cardiovasc Interv
; 96(2): E110-E118, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31625262
11.
Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial.
Lancet
; 392(10154): 1235-1245, 2018 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30253879
12.
Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial.
Am Heart J
; 198: 25-32, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653644
13.
High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial.
Cardiovasc Drugs Ther
; 32(6): 567-576, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30143879
14.
Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction.
Heart Vessels
; 33(9): 978-985, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29541845
15.
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
Lancet
; 388(10060): 2607-2617, 2016 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806902
16.
Late clinical outcome of stent trials: a matter of life or death?
Lancet
; 392(10149): 713-714, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30170847
17.
Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease.
Atherosclerosis
; 392: 117488, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598970
18.
Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention.
Front Cardiovasc Med
; 10: 1160201, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37745109
19.
Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease.
Int J Cardiol
; 374: 27-32, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36496036
20.
Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials.
Cardiovasc Diagn Ther
; 13(4): 673-685, 2023 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37675090